FDA Inspection 924112 — Andrew Krystal, M.D. - Clinical Investigator
The FDA completed an inspection of Andrew Krystal, M.D. - Clinical Investigator on April 13, 2015 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 13, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Francisco, CA (United States)
Additional Details
Clinical Investigator (CI)